Anika reports q4 earnings per share $0.28

Anika reports fourth quarter and full year 2019 financial results.q4 earnings per share $0.28.sees fy 2020 revenue $160 million to $165 million.q4 revenue $29.8 million versus refinitiv ibes estimate of $27.6 million.q4 adjusted non-gaap earnings per share $0.43 excluding items.q4 earnings per share estimate $0.42 -- refinitiv ibes data.anika therapeutics - total revenue for q4 of 2019 increased 10% year-over-year to $29.8 million, compared to $27.0 million for q4 of 2018.anika therapeutics - co expects total revenue to be in range of $160 million to $165 million for the full year of 2020.anika therapeutics - capital expenditures are expected to be between $5 million and $7 million for 2020.
ANIK Ratings Summary
ANIK Quant Ranking